GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.
GE HealthCare (GEHC) announced the 510(k) submission to the FDA for CleaRecon DL, deep learning technology, designed to improve the quality of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback